Initial Trials With Susceptibility-Based and Empiric Anti-H. pylori Therapies in Mongolia

Initial Trials With Susceptibility-Based and Empiric Anti-H. pylori Therapies in Mongolia

Background: Mongolia has a high prevalence of Helicobacter pylori infection and gastric cancer. We conducted a prospective, randomized, single-blind study to evaluate the efficacy of common regimens in Mongolia and to obtain specimens for susceptibility testing.Methods: Empiric treatments: 270 patie...

Full description

Bibliographic Details
Main Authors: Tsogt-Ochir Byambajav, Namdag Bira, Gotov Choijamts, Duger Davaadorj, Boldbaatar Gantuya, Tserenchimed Sarantuya, Gidaagaya Sarantuya, Altangerel Enkhtsetseg, Dungubat Erdenetsogt, Adiyasuren Battulga, Tegshee Tserentogtokh, Takeshi Matsuhisa, Yoshio Yamaoka, Khasag Oyuntsetseg
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Pharmacology
Subjects:
Helicobacter pylori
antibiotic resistance
eradication therapy
empirical therapy
Mongolia
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00394/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00394/full

Similar Items